Bulletin
Investor Alert

BioNTech SE ADR

NAS: BNTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/214419716/composite

$

161.00

Change

+0.65 +0.41%

Volume

Volume 20,654

Aug 12, 2022, 7:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/214419716/composite

Previous close

$ 158.59

$ 160.35

Change

+1.76 +1.11%

Day low

Day high

$158.58

$161.60

Open
Open: 160.50

52 week low

52 week high

$117.08

$390.00

Open

Market cap

$38.91B

Average volume

1.12M

P/E ratio

3.06

Rev. per Employee

$7.80M

EPS

52.32

Dividend

1.53

Div yield

N/A

Ex dividend date

6/2/22

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bntx

MarketWatch News on BNTX

  1. Stocks Waver Ahead of This Week's Inflation Data

    4:09 p.m. Aug. 8, 2022

    - Joe Woelfel

  2. BioNTech Misses Earnings Estimates

    11:10 a.m. Aug. 8, 2022

    - Angela Palumbo

  3. Tesla, Palantir, Global Blood and More Stock Market Movers

    7:22 a.m. Aug. 8, 2022

    - Angela Palumbo

  4. BioNTech affirms 2022 COVID-19 vaccine revenue EUR13 bln-EUR17 bln

    6:05 a.m. Aug. 8, 2022

    - Tomi Kilgore

  5. BioNTech Q2 share of COVID-19 gross profit ER557.0 mln

    6:05 a.m. Aug. 8, 2022

    - Tomi Kilgore

  6. BioNTech Q2 EUR3.20 bln vs. EUR5.31 bln a year ago; FactSet consensus EUR3.88 bln

    6:03 a.m. Aug. 8, 2022

    - Tomi Kilgore

  7. BioNTech Q2 FactSet EPS consensus EUR7.08

    6:02 a.m. Aug. 8, 2022

    - Tomi Kilgore

  8. BioNTech Q2 EPS EUR6.45 vs. EUR10.77 a year ago

    6:02 a.m. Aug. 8, 2022

    - Tomi Kilgore

  9. Pfizer and BioNTech will evaluate vaccine in U.S.-based study involving 200 participants aged 18 to 55

    6:49 a.m. July 27, 2022

    - Ciara Linnane

  10. Pfizer and BioNTech are seeking a vaccine with more robust, longer-lasting immune response against COVID

    6:48 a.m. July 27, 2022

    - Ciara Linnane

  11. Loading more headlines...
/news/nonmarketwatch/company/us/bntx

Other News on BNTX

  1. CDC eases COVID guidance for unvaccinated people

    3:26 p.m. Aug. 11, 2022

    - Seeking Alpha

  2. Pfizer Is A Solid High-Yielding Idea

    12:50 p.m. Aug. 11, 2022

    - Seeking Alpha

  3. Tracking Baillie Gifford's 13F Portfolio - Q2 2022 Update

    9:58 p.m. Aug. 9, 2022

    - Seeking Alpha

  4. Why BioNTech Was Tumbling Again Today

    3:25 p.m. Aug. 9, 2022

    - Motley Fool

  5. Company News for Aug 9, 2022

    9:39 a.m. Aug. 9, 2022

    - Zacks.com

  6. GeoVax: Possible Vaccine Advancements In 2 Big Indications

    7:40 p.m. Aug. 8, 2022

    - Seeking Alpha

  7. Most Parents Say No to Covid-19 Vaccines for Toddlers

    4:07 p.m. Aug. 8, 2022

    - Jared S. Hopkins

  8. BioNTech SE (BNTX) Q2 2022 Earnings Call Transcript

    4:00 p.m. Aug. 8, 2022

    - Motley Fool

  9. Why BioNTech Was a Sickly Stock on Monday

    3:20 p.m. Aug. 8, 2022

    - Motley Fool

  10. BioNTech SE 2022 Q2 - Results - Earnings Call Presentation

    12:54 p.m. Aug. 8, 2022

    - Seeking Alpha

  11. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/bntx

Press Releases on BNTX

  1. Pfizer to Buy Global Blood Therapeutics

    9:57 a.m. Aug. 8, 2022

    - Baystreet.ca

  2. How the price action of Biontech Se (BNTX) is used to our Advantage

    10:14 p.m. Aug. 5, 2022

    - Stock Traders Daily

  3. Light Week for Economic News

    4:27 p.m. Aug. 5, 2022

    - Baystreet.ca

  4. When the Price of Biontech Se BNTX Talks, People Listen

    6:04 a.m. July 27, 2022

    - Stock Traders Daily

  5. Biontech Se (BNTX) Trading Report

    10:03 p.m. July 13, 2022

    - Stock Traders Daily

  6. Biontech Se BNTX Proactive Strategies

    4:15 a.m. July 4, 2022

    - Stock Traders Daily

  7. Cheap Stocks To Buy Today? 3 Health Care Stocks For Your Watchlist

    12:30 p.m. June 27, 2022

    - StockMarket.com

  8. Trading Biontech Se BNTX With Integrated Risk Controls

    10:04 a.m. June 24, 2022

    - Stock Traders Daily

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.